Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Legend Biotech $487 million IPO
Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend Biotech Corporation of 21,188,750 American Depositary Shares, each…
Sands China $1.5 billion notes offering
Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S notes offering by Sands China Ltd. of $800 million of its 3.800% senior notes due 2026…
Beijing Hongkun $55 million high-yield notes offering
Davis Polk advised Hongkong Ideal Investment Limited Beijing (the “Issuer”) on its $55 million Regulation S offering of 14.750% guaranteed senior notes due 2022, to be consolidated and form…
Sea $1.15 billion convertible senior notes offering
Davis Polk advised the initial purchaser in connection with a Rule 144A and Regulation S offering by Sea Limited of $1.15 billion aggregate principal amount of its 2.375% convertible…
Back to top